Astorg has announced that it will acquire OPEN Health from Amulet Capital Partners. OPEN Health, headquartered in London, UK, is a leader in scientific communications, health economics and outcomes research, and market access services. CEO Rob Barker and OPEN Health’s management team will continue […]
Takeda CEO Signals Global Crises Could Force Drugmakers to Lower Prices
In a letter to shareholders sent Tuesday, May 31st, Takeda CEO Christophe Weber said that the escalating series of global crises may force drugmakers to reduce drug prices. As governments reel from the back-to-back impacts of the COVID-19 pandemic and energy shortages caused by Russia’s invasion of […]
Catalyst Shareholders Say $60 Million Vertex Deal Could’ve Happened in 2019
Shortly after Catalyst Biosciences closed its deal with Vertex, shareholders have come forward expressing that it was too little, too late. Catalyst sold its preclinical complement drugs to Vertex for $60 million, following two rounds of layoffs and the shuttering of its hemophilia program. The […]
What Holds Back Diversity in Clinical Trials?
Despite an industry-wide push for diversity, equity, and inclusion efforts, clinical trials still suffer from a lack of diversity. Patient populations are much more diverse than those represented in most trials, limiting applicability to these groups, who may have different responses to the same […]
Pharma Climbs its Way Up the Fortune 500
This year’s Fortune 500 saw several pharmaceutical companies climbing the ranks, while some experienced exponential growth. Gilead, for example, grew by almost 5000%. Surprisingly, this wasn’t enough for it to maintain its spot, falling from no. 116 to 123. In contrast, Pfizer climbed up an […]
Pharmaceutical Compliance Congress Canada 2022
Taking place in Toronto, ON from June 7-9, the Pharmaceutical Compliance Congress Canada is the leading conference in Canada for life sciences ethics and compliance professionals. The event allows industry professionals to connect with their colleagues through panel discussions, case studies, talks […]
Bavarian Nordic in Talks with Governments to Produce Monkeypox Vaccines
As more cases of monkeypox spring up across the world, the German government has ordered 40,000 doses of monkeypox vaccines from Bavarian Nordic. The vaccine manufacturer said that it is in talks with several world governments, each looking to vaccinate vulnerable populations and build its […]
The Importance of Integrated Service Offerings in Biopharma
Smaller biotechs have pivoted in recent years from selling products early in the development cycle to holding onto their assets. However, managing every stage of the development process is beyond the reach of many firms. In a recent Drug Discovery Online article, David K. Lyon, Ph.D, of Lonza […]
Diabetes, Psoriasis, and Arthritis are Top Drug Categories for Ad Spending
Research from MediaRadar has identified diabetes as the largest therapy area for pharma direct-to-customer (DTC) advertising spending in 2021. Also in the top five are psoriasis, arthritis, HIV/AIDs, and breast cancer. Approximately $777 million was spent on ads for diabetes medicines and devices […]
European Medicines Agency Recommends Suspension of 100 Drugs Due to CRO Data Concerns
Data integrity issues at Synchron Research Services spurred the European Medicines Agency to recommend the suspension of 100 drugs. Synchron, an India-based CRO, runs quality control tests for generics from several manufacturers. The firm has faced similar critiques from the US Food and Drug […]
